Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for making chitosan nanoparticle-pcDNA3.1-hVEGF gene complex

A chitosan nanoparticle, -pcdna3.1-hvegf technology, applied in the field of biomedical engineering, can solve problems such as easy degradation, difficult material compounding, and protein variability

Inactive Publication Date: 2005-01-19
INST OF BASIC MEDICAL SCI ACAD OF MILITARY MEDICAL SCI OF PLA
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The development of tissue engineering has provided the possibility for the physiological replacement repair of tissue and organ defects, but the research and development of tissue engineering products are currently facing a common problem, that is, when the thickness of the constructed tissue exceeds 4 mm, the intermediate cellular components Therefore, it is urgent to find a new method to improve the vascularization level of tissue engineered tissues
Previous studies have combined cytokines that can promote angiogenesis, such as vascular endothelial growth factor (VEGF), etc., with scaffold materials to improve the vascularization level of tissue engineered tissues. Difficult, easy to inactivate, and easy to degrade in the body, the application effect is not ideal

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for making chitosan nanoparticle-pcDNA3.1-hVEGF gene complex

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0007] Embodiment 1 Construction of recombinant plasmid pcDNA3.1-hVEGF

[0008] Plasmid pcDNA3.1 is a eukaryotic expression vector, which constructs a human cytomegalovirus promoter, which can express and regulate the inserted foreign gene. The plasmid itself carries the gene coding sequence of hVEGF, and can express and produce hVEGF under the action of its own expression control elements. There are 17 restriction restriction sites on the multiple cloning site of the plasmid. The BamHI and KpnI regions can be cut with restriction endonucleases, and then T4DNA ligase is used to connect the exogenous gene that has also been double-digested with BamHI and KpnI, so that it is placed under the control of the CMV promoter of human cytomegalovirus, In this way, the eukaryotic expression vector of the foreign gene is constructed (see accompanying drawing).

Embodiment 2

[0009] The preparation of embodiment 2 chitosan nanoparticles

[0010] Adjust the chitosan solution with a certain concentration to pH5.5 with 1N HCl, and take 200ul and a certain concentration of Na 2 Add 200 ul of SO4 solution into the chitosan solution, and quickly mix with a vortex mixer for 30 seconds to obtain the chitosan nanoparticle suspension.

[0011] Determination of morphology, particle size and particle size distribution: the purpose is to investigate the influence of various factors on the preparation process. Take a small amount of nanoparticle suspension and drop it on the copper grid covered with carbon film, let it stand for 2 minutes, blot the suspension with filter paper, then add 2% phosphotungstic acid for negative staining for 2 minutes, and observe the nanoparticle under a transmission electron microscope. granular form. The transmission electron microscope photos are measured with a scale and the particle size is calculated according to the magnific...

Embodiment 3

[0014] Embodiment 3 chitosan nanoparticles-pcDNA 3.1 -Construction of hVEGF gene complex

[0015] Prepared by coacervation method (all the operations are carried out under sterile conditions): first prepare 0.03% chitosan (Sigma) solution, adjust the pH value to 5.5 with 1N HCl, and filter to sterilize with a 0.22 μm filter membrane. with 75mM Na 2 SO 4 (Analytical grade, Beijing Chemical Plant) solution (0.22μm membrane filtration sterilization) to dissolve pcDNA 3.1 -hVEGF recombinant plasmid, so that the final concentration is 200 μg / ml. Take 200 μl of 0.03% chitosan solution and 200 μl of 75 mM Na 2 SO 4 The solutions were placed in an aqueous solution at 55° C. for 20 minutes at a constant temperature. Accurately pipette 200μl of Na 2 SO 4 The solution was added to the chitosan solution and quickly mixed on a vortex mixer for 30 seconds to make chitosan nanoparticles-pcDNA 3.1 -hVEGF suspension, lyophilized into nanoparticles at low temperature, and stored at 4°C...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
The average particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention relates to a method for making chitosan nanoparticle-pcDNA3.1-hVEGF gene complex, wherein chitosan and sodium sulphate are reacted for obtaining chitosan nano granules, which is used as a carrying agent to construct the chitosan nano granule-pcDNA[3,1]-hVEGF gene complex. The complex can be applied into tissue engineering.

Description

technical field [0001] The invention belongs to the field of biomedical engineering, in particular to a chitosan nanoparticle-pcDNA 3.1 - Construction of the hVEGF gene complex. Background technique [0002] Chitosan is a natural polymer polysaccharide extracted from shrimp skin and crab shell. It is composed of glucosamine and N-acetyl-glucosamine combined by β-1.4 glycoside bonds. Its molecular weight is generally tens of thousands to hundreds of thousands. There are many free amino groups on the chitosan macromolecular bonds. Under acidic conditions, these free amino groups are protonated to make the chitosan macromolecules positively charged. Chitosan is biodegradable and has good biocompatibility with the human body. Chitosan is also bioadhesive and can be used as a carrier. Chitosan has been widely used in the field of biomedicine and has shown good application prospects. [0003] Nanoparticle technology is a hotspot in current material science and physics research....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/18A61K48/00A61P9/10C07H21/04C12N15/12C12N15/79C12P19/26C12Q1/68
Inventor 王常勇齐子荣郭希民段翠密孙志杰
Owner INST OF BASIC MEDICAL SCI ACAD OF MILITARY MEDICAL SCI OF PLA